Alzamend Neuro (ALZN) Current Assets (2020 - 2026)
Alzamend Neuro (ALZN) reported Current Assets of $8.25 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), up 39.2% from $5.93 million a year earlier and up 367.8% from the prior quarter.
Powered by 
Analysis
Alzamend Neuro (ALZN) Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2026 (ended Apr 30, 2026), Alzamend Neuro posted Current Assets of $1.76 million, down 57.8% from FY2025.
- Current Assets has a five-year compound annual growth rate of -9.5% (FY2021 to FY2026).
- By fiscal year, Current Assets came in at $4.18 million in FY2025 (+817.6%), $455,242 in FY2024 (-92.2%), $5.84 million in FY2023 (-59.5%) and $14.41 million in FY2022 (+394.9%).
- The fiscal Q1 2027 figure ranks as the highest quarterly Current Assets since fiscal Q3 2023.
- Year over year, Current Assets gained in five of the last eight quarters, with growth averaging 273.1%.
- The high point for year-over-year Current Assets in five years was fiscal Q4 2025 (growth of 817.6%); the low point was fiscal Q3 2024 (a decline of 92.9%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $1.76 million (Q4 2026), $3.7 million (Q3 2026) and $4.72 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Alzamend Neuro | 5.73 Mn | -9.73 Mn | - | 8.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 8.25 Mn |
| Apr 30, 2026 | 1.76 Mn |
| Jan 31, 2026 | 3.70 Mn |
| Oct 31, 2025 | 4.72 Mn |
| Jul 31, 2025 | 5.93 Mn |
| Apr 30, 2025 | 4.18 Mn |
| Jan 31, 2025 | 3.95 Mn |
| Oct 31, 2024 | 4.77 Mn |
| Jul 31, 2024 | 1.42 Mn |
| Apr 30, 2024 | 455,242.00 |
| Jan 31, 2024 | 593,605.00 |
| Oct 31, 2023 | 781,881.00 |
| Jul 31, 2023 | 2.41 Mn |
| Apr 30, 2023 | 5.84 Mn |
| Jan 31, 2023 | 8.42 Mn |
| Oct 31, 2022 | 10.33 Mn |
| Jul 31, 2022 | 12.11 Mn |
| Apr 30, 2022 | 14.41 Mn |
| Jan 31, 2022 | 12.43 Mn |
| Oct 31, 2021 | 14.50 Mn |
API Access
Alzamend Neuro Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();